Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAG therapy versus antibiotic prophylaxis for recurrent urinary tract infection
NL-OMON54106Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Ialuril, nitrofurantoin and trimethoprim in urinary tract infection (UTI) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Number of urinary tract infections per patient per treatment. Started Oct 2022; status: recruiting.
02
Drugs
Ialurilnitrofurantointrimethoprim
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NL-OMON54106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54106.